Literature DB >> 20200003

Behavioural abnormalities in children with nephrotic syndrome.

Om P Mishra1, Biswanath Basu, Shashi K Upadhyay, Rajniti Prasad, Franz Schaefer.   

Abstract

BACKGROUND: Glucocorticoid therapy in children with nephrotic syndrome can lead to many adverse effects including behavioural problems. The present study was undertaken to assess the changes in individual behaviour among different sub-groups of patients with idiopathic nephrotic syndrome (INS) and also to find out the relationship, if any, between different behavioural problems with cumulative dose of steroid therapy.
METHODS: This was a prospective hospital-based study. We assessed behavioural patterns in 131 children and adolescents with steroid-responsive INS aged 1.5-15 years. Fifty healthy children matched for age and gender were included to serve as controls. The Achenbach Child Behaviour Checklist was used to assess individual behaviour. Patients were sub-grouped according to age (1.5-5 and 6-15 years) and disease status (first attack before and after 12-week prednisolone, infrequent relapser, frequent relapser/steroid-dependent).
RESULTS: All groups had significantly elevated mean behavioural abnormality scores for dimensions assessed in both age groups, except rule-breaking behaviour. Besides sleep problems, frequent relapsers/steroid-dependent patients exhibited maximum scores in comparison to first attack and infrequent relapsers in the 1.5- to 5-year age group. Total and individual behavioural scores showed close associations with cumulative prednisolone dose in both groups.
CONCLUSIONS: It is evident that nephrotic syndrome patients should be given due consideration in clinical practice for behavioural abnormalities especially after steroid therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20200003     DOI: 10.1093/ndt/gfq097

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  12 in total

1.  The impact of pediatric nephrotic syndrome on families.

Authors:  Sulagna Mitra; Sushmita Banerjee
Journal:  Pediatr Nephrol       Date:  2011-05-29       Impact factor: 3.714

Review 2.  Corticosteroid therapy for nephrotic syndrome in children.

Authors:  Deirdre Hahn; Elisabeth M Hodson; Narelle S Willis; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2015-03-18

3.  Lower prednisone dosing for steroid-sensitive nephrotic syndrome relapse: a prospective randomized pilot study.

Authors:  Yael Borovitz; Hadas Alfandary; Orly Haskin; Shely Levi; Shulamit Kaz; Miriam Davidovits; Amit Dagan
Journal:  Eur J Pediatr       Date:  2019-11-14       Impact factor: 3.183

Review 4.  Corticosteroid therapy for nephrotic syndrome in children.

Authors:  Deirdre Hahn; Susan M Samuel; Narelle S Willis; Jonathan C Craig; Elisabeth M Hobson
Journal:  Cochrane Database Syst Rev       Date:  2020-08-31

5.  Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.

Authors:  Karnika Raja; Ami Parikh; Hazel Webb; Daljit Hothi
Journal:  Pediatr Nephrol       Date:  2016-09-27       Impact factor: 3.714

6.  Behavioural abnormalities in children with new-onset nephrotic syndrome receiving corticosteroid therapy: results of a prospective longitudinal study.

Authors:  Aishvarya Upadhyay; Om P Mishra; Rajniti Prasad; Shashi K Upadhyay; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2015-09-28       Impact factor: 3.714

7.  Impact of rituximab on height and weight in children with refractory steroid-dependent nephrotic syndrome.

Authors:  Mai Sato; Shuichi Ito; Masao Ogura; Koichi Kamei
Journal:  Pediatr Nephrol       Date:  2014-03-07       Impact factor: 3.714

8.  Psychosocial and cognitive function in children with nephrotic syndrome: association with disease and treatment variables.

Authors:  Maria Alexandra Magiakou; Gerasimos Kolaitis; Panagiota Manti; George Giannakopoulos; Elena Giouroukou; Helen Georgaki-Angelaki; Constantinos J Stefanidis; Andromahi Mitsioni; Nikolaos Stergiou; Constantinos Mihas; George P Chrousos
Journal:  Biopsychosoc Med       Date:  2013-04-23

9.  Assessment of behavior abnormalities of corticosteroids in children with nephrotic syndrome.

Authors:  Doaa Mohammed Youssef; Mohamed Mohamed Abdelsalam; Ali Mohamed Abozeid; Usama Mahmoud Youssef
Journal:  ISRN Psychiatry       Date:  2013-04-16

Review 10.  Optimizing the corticosteroid dose in steroid-sensitive nephrotic syndrome.

Authors:  Martin T Christian; Andrew P Maxted
Journal:  Pediatr Nephrol       Date:  2021-02-20       Impact factor: 3.651

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.